Hepatocellular Carcinoma Immunopathogenesis: Clinical Evidence for Global T Cell Defects and an Immunomodulatory Role for Soluble CD25 (sCD25)

被引：0
|
作者：
Roniel Cabrera
Miguel Ararat
Mengde Cao
Yiling Xu
Clive Wasserfall
Mark A. Atkinson
Chen Liu
David R. Nelson
机构：
[1] University of Florida,Section of Hepatobiliary Diseases, Department of Medicine
[2] University of Florida,Department of Pathology, Immunology, and Laboratory Medicine
来源：
Digestive Diseases and Sciences | 2010年 / 55卷
关键词：
Soluble IL-2 receptor alpha chain (sIL-2RA); IL-2 signaling; T cell immunosuppression; Liver cancer; Serum; Soluble factors; Tumor tolerance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：484 / 495
页数：11
相关论文
共 38 条
  • [31] CD4+CD25+CD127low regulatory T cells play predominant anti-tumor suppressive role in hepatitis B virus-associated hepatocellular carcinoma
    Sharman, Shreya
    Khoslal, Ritu
    David, Paul
    Rastogi, Archana
    Vyas, Ashish
    Singh, Dileep
    Bhardwaj, Ankit
    Sahney, Amrish
    Maiwall, Rakhi
    Sarin, Shiv Kumar
    Trehanpati, Nirupma
    FRONTIERS IN IMMUNOLOGY, 2015, 6 : 1 - 9
  • [32] Serum soluble CD25 may predict the early therapeutic response in pediatric patients with B-cell non-Hodgkin's lymphoma(BNHL)during autologous chimeric antigen receptor T cell(CAR-T) therapy
    Guo, Jing
    Zhang, Yonghong
    Du, Juan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [33] Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients
    Li, Fenge
    Guo, Zhi
    Lizee, Gregory
    Yu, Haipeng
    Wang, Haitao
    Si, Tongguo
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (09) : 1357 - 1365
  • [34] SERUM IL10 AND CIRCULATING CD4+CD25high REGULATORY T CELL NUMBERS AS PREDICTORS OF CLINICAL OUTCOME AND SURVIVAL IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Alhamarneh, Osama
    Agada, Frank
    Madden, Leigh
    Stafford, Nicholas
    Greenman, John
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (03): : 415 - 423
  • [35] Renal cell carcinoma may evade the immune system by converting CD4+Foxp3- T cells into CD4+CD25+Foxp3+ regulatory T cells: Role of tumor COX-2-derived PGE2
    Li, Jinfeng
    Feng, Guiwen
    Liu, Jia
    Rong, Ruiming
    Luo, Feifei
    Guo, Liang
    Zhu, Tongyu
    Wang, Guomin
    Chu, Yiwei
    MOLECULAR MEDICINE REPORTS, 2010, 3 (06) : 959 - 963
  • [36] Serum IL10, IL12 and circulating CD4+CD25high T regulatory cells in relation to long-term clinical outcome in head and neck squamous cell carcinoma patients
    Green, Victoria L.
    Irune, Ekpemi
    Prasai, Amit
    Alhamarneh, Osama
    Greenman, John
    Stafford, Nicholas D.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (03) : 833 - 839
  • [37] The role of tumor cells in the modification of T lymphocytes activity - the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I
    Starska, Katarzyna
    Glowacka, Ewa
    Kulig, Andrzej
    Lewy-Trenda, Iwona
    Brys, Magdalena
    Lewkowicz, Przemyslaw
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (04) : 579 - 592
  • [38] 12-DEOXYPHORBOL-13-O-PHENYLACETATE 20 ACETATE [AN AGONIST OF PROTEIN-KINASE C-BETA-1 (PKC-BETA-1)] INDUCES DNA-SYNTHESIS, INTERLEUKIN-2 (IL-2) PRODUCTION, IL-2 RECEPTOR ALPHA-CHAIN (CD25) AND BETA-CHAIN (CD122) EXPRESSION, AND TRANSLOCATION OF PKC-BETA ISOZYME IN HUMAN PERIPHERAL-BLOOD LYMPHOCYTES - EVIDENCE FOR A ROLE OF PKC-BETA-1 IN HUMAN T-CELL ACTIVATION
    AGGARWAL, S
    LEE, S
    MATHUR, A
    GOLLAPUDI, S
    GUPTA, S
    JOURNAL OF CLINICAL IMMUNOLOGY, 1994, 14 (04) : 248 - 256
1234